Christoph Lange was recently appointed as Medical Director of the Research Center Borstel. From here, he substantially contributes to clinical tuberculosis research in Europe, also monitoring the
Prof Rolf Müller was honoured with the Inhoffen Prize for his outstanding research in the field of microbial natural product discovery, particularly from Myxobacteria. Müller heads the Helmholtz
Early detection of antibiotic resistant pathogens can be life-saving. DZIF-scientists at the Institute for Medical Microbiology, Immunology and Hygiene, University of Cologne, have developed an
Human herpesvirus 6 infects most people all over the world. It is usually well controlled by the body, but it can cause diseases in immunocompromised individuals. As reported in ‘PLOS Pathogens’, DZIF
A new and rapid method for diagnosing pulmonary tuberculosis has been successfully developed at the Research Center Borstel. This innovative method constitutes an important building block for optimal
Worldwide, approximately 260 million people suffer from chronic hepatitis B which is currently incurable. However, there is now a shimmer of hope on the horizon as scientists at the DZIF have
The global increase of tuberculosis patients is alarming, particularly the increase of cases of so-called multidrug-resistant tuberculosis (MDR-TB) in which the pathogen is insensitive to the most
Jörg Janne Vehreschild started his professional career as a programmer. However, he soon decided to pursue his second passion and began his medical studies a year later. Today, at only 39, Vehreschild
Pseudomonas aeruginosa bacteria are hospital germs and are often resistant to common antibiotics. They can infect all human organs and implants, and can persist in the body for long periods of time in
Dr Silvia Portugal, Head of a DZIF junior research group, has received 1.5 million euros’ funding from the European Research Council. At the Heidelberg University Hospital, together with an
